Skip to content
healthcare.dev

Hydroxyzine Pamoate

NDC 0555-0302, Hydroxyzine Pamoate, capsule, from Teva Pharmaceuticals USA, Inc..

Product NDC
0555-0302
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA088487
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0555-0302 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROXYZINE PAMOATE50 mg/1

Pharmacologic classes

Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]

Package NDCNDC-11Package
0555-0302-0200555030202100 CAPSULE in 1 BOTTLE (0555-0302-02)
0555-0302-0400555030204500 CAPSULE in 1 BOTTLE (0555-0302-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/06068fff-2e79-4721-bcc7-b0938aa20e7a
  • NADAC price for package 00555030202

    GET /v1/drugs/nadac/00555030202
  • NADAC price for package 00555030204

    GET /v1/drugs/nadac/00555030204

Use it

Look up 0555-0302 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0555-0302 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0555-0302. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.